Concert to seek approval for hair loss drug after second study success

Concert Pharmaceuticals, a small biotechnology company based in Lexington, Massachusetts, plans to seek Food and Drug Administration approval for its experimental hair loss drug after reporting success in the second of two late-stage clinical trials.